FIELD: pharmaceutical industry.
SUBSTANCE: claimed composition for sublingual application contains apomorphine as active ingredient and succinic acid as apomorfine stabilizer and filler, as well as other additives.
EFFECT: sublingual tablet with sufficient strength and resolvability.
4 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION INCLUDING CHOLINE ALFOSCERATE AND HOPANTENIC ACID (OR ITS SALT) FOR TREATMENT OF CEREBRAL CIRCULATORY INSUFFICIENCE AND ERECTAL DYSFUNCTION | 2009 |
|
RU2391095C1 |
| COMPOSITION OF 3-OXY-6-METHYL-2-ETHYLPYRIDINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT IN TABLETTED FORM, METHOD FOR MAKING THEREOF, AND THERAPY | 2007 |
|
RU2384330C2 |
| PHARMACEUTICAL COMPOSITION OF FABOMOTIZOLE DIHYDROCHLORIDE | 2022 |
|
RU2828872C2 |
| PHARMACEUTICAL DOSED FORMULATION FOR DELIVERY THROUGH MUCOSA | 2003 |
|
RU2285520C2 |
| AGENT FOR TREATMENT OF PROSTATE DISEASE | 2005 |
|
RU2278681C1 |
| AGENT BASED ON DRY MOTHERWORT EXTRACT AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2589507C1 |
| PHARMACEUTICAL ANTIFUNGAL COMPOSITION BASED ON A CHLOROPHENYLBUTANEDIONE DERIVATIVE AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2707286C1 |
| PHARMACEUTICAL COMBINATION CONTAINING VINPOCETINE AND BETAHISTINE FOR TREATING CEREBRAL CIRCULATORY DEPRESSION | 2008 |
|
RU2386439C2 |
| PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
| COMPOSITION AND METHOD FOR PRODUCING A SOLID DOSAGE FORM CONTAINING (Z)-3-(2-OXO-2-(4-TOLYL)ETHYLIDENE)PIPERAZIN-2-ONE | 2017 |
|
RU2657526C1 |
